Sort
40,608 grants matching “prostate cancer”
SMALL MOLECULES TARGETING AR IN CASTRATION-RESISTANT PROSTATE CANCER
$1,140,426University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2016 · Department of Defense
NEW AWARD - EFFECTIVE DATE: 15 JUN 2020 DATE SIGNED: 11-JUN-2020 DATE DISTRIBUTED: 6/11/2020, FAADC DATE: 6/11/2020...INTERACTIONS BETWEEN FAM3B AND ANDROGEN RECEPTOR IN DRIVING PROSTATE CANCER PROGRESSION
$1,140,000The Administrators Of Tulane Educational Fund · · FY2020 · Defense Health Agency
IDENTIFICATION OF SPATIAL REGULATORY HETEROGENEITY IN PROSTATE CANCER USING SINGLE-NUCLEUS JOINT PROFILING OF CHROMATIN ARCHITECTURE AND DNA METHYLATION
$1,139,336University Of California, Los Angeles · · FY2022 · Department of the Army
Impacts of Genetic and Environmental Factors on Reproductive Organ Development
$1,138,644Hung Chang Yao · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$1,138,422Paul Kvale · Henry Ford Health System · N01 · FY2009 · CA
PROMOTING EQUITY THROUGH A CULTURALLY TAILORED PROSTATE CANCER GENETICS VIDEO FOR AFRICAN AMERICAN MALES FOR IMPACT LONG TERM: PREVAIL STUDY
$1,137,950Yale Univ · · FY2022 · Defense Health Agency
TARGETING DNA REPAIR PATHWAYS IN PROSTATE CANCER
$1,137,760The University Of Texas Southwestern Medical Center · · FY2017 · Department of the Army
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,137,453Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2017 · CA
GENETICALLY DIRECTED HSD3B1 THERAPEUTICS FOR METASTATIC PROSTATE CANCER
$1,137,102The Cleveland Clinic Foundation · · FY2020 · Defense Health Agency
Center for Interventional Oncology
$1,137,060Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Clinical Nursing and Data Management Core
$1,136,093William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,135,587Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2018 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$1,135,499David John Hunter · Brigham And Women'S Hospital · U01 · FY2010 · CA
2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,134,995Timothy Turner · Tuskegee University · U54 · FY2024 · CA
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic
$1,134,000Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2011 · CA
NEW AWARD - TARGETING THE CPSF COMPLEX TO PREVENT EXPRESSION OF AR VARIANTS IN PROSTATE CANCER...EFFECTIVE DATE-01 JUL 2020 DATE SIGNED 19-MAY-2020 DISTRIBUTED 5/21/2020 FAADC 5/21/2020
$1,133,635Regents Of The University Of Minnesota · · FY2020 · Defense Health Agency
Animal Model and Genotyping Core Support Facility
$1,133,495Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Novel Molecular Therapies of Prostate Cancer
$1,131,982Dario C. Altieri · Wistar Institute · P01 · FY2013 · CA
Environmental Exposure and DNA Damage
$1,131,566Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,131,504Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2020 · CA
Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes
$1,131,249Michael Dean · Basic Sciences · Z01 · FY2007 · CA
CDK8/19 inhibitors for therapy of advanced prostate cancer
$1,130,935Mengqian Chen · Senex Biotechnology, Inc. · R44 · FY2020 · CA
CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE
$1,130,266Shafiq A Khan · Clark Atlanta University · P20 · FY2016 · MD
NCI Cancer Screening Research Network: Coordinating and Communication Center
$1,130,173Garnet L. Anderson · Fred Hutchinson Cancer Center · UG1 · FY2024 · CA
DEVELOPMENT OFSUMO PROTEASE INHIBITORS AS A NOVEL STRATEGY FOR DUAL-ACTION PROSTATE CANCER THERAPY
$1,129,642Regents Of The University Of Michigan · · FY2012 · Department of Defense